Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Affiliations

¹ Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, School of Medicine, Wayne State University, Detroit, MI, and Detroit Receiving Hospital, Detroit, MI.
² Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA.
³ Albany College of Pharmacy and Health Sciences, Albany, NY, and Stratton VA Medical Center, Albany, NY.
⁴ School of Medicine, Wayne State University, Detroit, MI, and Detroit Receiving Hospital, Detroit, MI.
⁵ Department of Pediatrics, Division of Infectious Diseases, University of California at San Diego, La Jolla, CA, and Rady Children's Hospital San Diego, San Diego, CA.
⁶ Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, and Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
⁷ University of Michigan College of Pharmacy, Ann Arbor, MI.
⁸ University of Southern California School of Pharmacy, Los Angeles, CA.
⁹ University of Minnesota College of Pharmacy, Minneapolis, MN.
¹⁰ University of Illinois College of Pharmacy, Chicago, IL.
¹¹ University of Arkansas for Medical Sciences College of Pharmacy & Arkansas Children's Hospital, Little Rock, AR.
¹² Albany Medical Center Hospital, Albany, NY.

Michael J Rybak et al. Am J Health Syst Pharm. 2020.

. 2020 May 19;77(11):835-864.

doi: 10.1093/ajhp/zxaa036.

¹ Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, School of Medicine, Wayne State University, Detroit, MI, and Detroit Receiving Hospital, Detroit, MI.
² Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA.
³ Albany College of Pharmacy and Health Sciences, Albany, NY, and Stratton VA Medical Center, Albany, NY.
⁴ School of Medicine, Wayne State University, Detroit, MI, and Detroit Receiving Hospital, Detroit, MI.
⁵ Department of Pediatrics, Division of Infectious Diseases, University of California at San Diego, La Jolla, CA, and Rady Children's Hospital San Diego, San Diego, CA.
⁶ Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, and Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
⁷ University of Michigan College of Pharmacy, Ann Arbor, MI.
⁸ University of Southern California School of Pharmacy, Los Angeles, CA.
⁹ University of Minnesota College of Pharmacy, Minneapolis, MN.
¹⁰ University of Illinois College of Pharmacy, Chicago, IL.
¹¹ University of Arkansas for Medical Sciences College of Pharmacy & Arkansas Children's Hospital, Little Rock, AR.
¹² Albany Medical Center Hospital, Albany, NY.

No abstract available

Keywords: nephrotoxicity; pharmacokinetics and pharmacodynamics; target attainment; vancomycin; vancomycin consensus guideline.

Comment in

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Rybak MJ, Le J, Lodise T, Levine D, Bradley J, Liu C, Mueller B, Pai M, Wong-Beringer A, Rotschafer JC, Rodvold K, Maples HD, Lomaestro BM. Rybak MJ, et al. J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057. J Pediatric Infect Dis Soc. 2020. PMID: 32659787 Free PMC article. No abstract available.
Transitioning from guideline approval to practical implementation of AUC-based monitoring of vancomycin.
Bland CM, Crosby CM, Orvin DL, Smith SE, Jones BM. Bland CM, et al. Am J Health Syst Pharm. 2021 Jul 9;78(14):1270-1272. doi: 10.1093/ajhp/zxab132. Am J Health Syst Pharm. 2021. PMID: 33772267 No abstract available.
Bayesian-estimated vancomycin area under the curve using a single trough concentration vs 2 concentrations.
Ho D, Arquiette J, Kim MK. Ho D, et al. Am J Health Syst Pharm. 2021 Sep 7;78(18):1663-1664. doi: 10.1093/ajhp/zxab233. Am J Health Syst Pharm. 2021. PMID: 34086869 No abstract available.